Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
about
IRF7: activation, regulation, modification and functionInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesInterferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuitMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaDual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytesInterferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.A toll-like receptor 2 pathway regulates the Ppargc1a/b metabolic co-activators in mice with Staphylococcal aureus sepsisViral transformation for production of personalized type I interferonsUp-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cellsNF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF)Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.Regulation of IRF7 through cell type-specific protein stability.TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway ActivationMUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3TLR-TRIF pathway enhances the expression of KSHV replication and transcription activator.Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic propertiesTumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7.Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.Expression of interferon regulatory factor 7 correlates with the expression of Epstein-Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.Colocalization of interferon regulatory factor 7 (IRF7) with latent membrane protein 1 (LMP1) of Epstein-Barr virus.The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.Human T-cell leukemia virus type 1 Tax protein stimulates the interferon-responsive enhancer element via NF-kappaB activity.Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7.Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 replication and transcription activator regulates viral and cellular genes via interferon-stimulated response elements.Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes.
P2860
Q24299740-7317C1D3-4F88-4B32-84E5-EE2C78948BACQ24646670-24913F06-4666-4FB0-9112-2DE8D01B24F4Q24683031-1172E9A4-5944-4409-8FCC-0AD7DAB0F164Q28472086-E6BB5E1D-C24E-429F-8C5D-E0113932C7E1Q30979226-D5CC7145-8F70-4DA7-834E-04157E7F917DQ33908810-6BBC9138-1E90-4A7C-862C-347E6ABB2CF0Q33987481-3BED6D5D-4766-4D47-80CB-8AAD7A726E59Q34038107-09DB9BB2-919C-4EF3-916A-05877AC3A383Q34118602-19ECF91B-4F92-44FF-BB44-B7A88BEE5B3FQ34234406-930279E8-279A-4C17-B5D1-749FE5B7178AQ34352790-A6CB65C1-4819-4A21-84BB-B832D4F8C036Q34405076-5D91B5ED-0D2C-4F03-A2E7-FB08FF024B25Q34532370-9F013D11-816B-4F96-B43E-8A98DE6C83ACQ34624150-C91D7639-5482-4CCE-BC9D-E3432C7BFFD2Q34979127-D059FD83-4F28-4DB5-ACE8-CF42EC5AA8C6Q35148066-B5A06878-99B3-468B-8493-72D60F105D94Q35634395-71A30277-8A84-448F-9074-7CF45A6FFB6CQ35635449-E0E79019-F2BF-4EE4-9720-3ADD164DA6CFQ35856781-ACC33EE2-91BB-48AA-9FE5-D73EDF8181B0Q35861199-99B6E8A4-C7A9-4849-B1BA-CCC49EEC857BQ36961875-99D90E14-D816-464C-B639-AEA136827DAFQ36984994-81B2E3C7-8959-43EA-B6C2-1BE14E213750Q37012458-8C106DDC-8520-4CC2-8F60-C144792B3B64Q37596432-E28CCF9A-8C73-48FD-98C9-D66B2A0CC362Q38631755-C3887ED6-EF79-4CC7-88E8-668287BDE667Q38728203-634BF26C-9002-4670-84F2-A2CDD0E8133BQ38998165-22D8A71B-DF54-4F11-A351-8E37DA6FD740Q39321358-66CE5442-0DE9-4903-9D4F-3A2FD0AB3629Q39537817-AEA0D5BA-2F59-4ACB-AA61-DA2BCB03DAA7Q39789708-C58ED757-6DB3-4A29-BDB1-2D2794F81C65Q40121289-89C8FEA8-C6D5-4F85-94DA-E0153498BD80Q40155828-BD1152EB-555B-4C9F-858F-72F591459495Q40266843-5E382DD8-4D87-4DD8-8479-E13A01DC35BAQ40318357-57F2BA8F-9598-4C0B-A231-B48847DAAA6EQ40467468-28566006-E1F2-451E-A714-3CD42653EB75Q40662131-B44BC2EB-8081-4514-AF8C-923A13FA0256Q40977047-70B2A9BA-CDE7-48F8-BF7A-2A81071A12D0Q41832453-E5F9096F-3D29-4737-AFED-F5D30E6DB376Q41995310-0134225B-DF76-4996-B05D-9126864B48CCQ44713676-D884B819-5749-4F4A-8569-6778C5565D8B
P2860
Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@ast
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@en
type
label
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@ast
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@en
prefLabel
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@ast
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@en
P2093
P2860
P1433
P1476
Intracellular signaling molecu ...... nterferon regulatory factor 7.
@en
P2093
P2860
P304
12393-12401
P356
10.1128/JVI.75.24.12393-12401.2001
P577
2001-12-01T00:00:00Z